Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, Mattheisen M, Wang Y, Coleman JRI, Gaspar HA, de Leeuw CA, Steinberg S, Whitehead Pavlides JM, Trzaskowski M, Byrne EM, Pers TH, Holmans PA, Richards AL, Abbott L, Agerbo E, Akil H, Albani D, Alliey-Rodriguez N, Als TD, Anjorin A, Antilla V, Awasthi S, Badner JA, Bækvad-Hansen M, Barchas JD, Bass N, Bauer M, Belliveau R, Bergen SE, Bøcker Pedersen C, Bøen E, Boks MP, Boocock J, Budde M, Bunney W, Burmeister M, Bybjerg-Grauholm J, Byerley W, Casas M, Cerrato F, Cervantes P, Chambert K, Charney AW, Chen D, Churchhouse C, Clarke TK, Coryell W, Craig DW, Cruceanu C, Curtis D, Czerski PM, Dale AM, de Jong S, Degenhardt F, Del-Favero J, DePaulo JR, Djurovic S, Dobbyn AL, Dumont A, Elvsåshagen T, Escott-Price V, Fan CC, Fischer SB, Flickinger M, Foroud TM, Forty L, Frank J, Fraser C, Freimer NB, Frisén L, Gade K, Gage D, Garnham J, Giambartolomei C, Giørtz Pedersen M, Goldstein J, Gordon SD, Gordon-Smith K, Green EK, Green MJ, Greenwood TA, Grove J, Guan W, Guzman-Parra J, Hamshere ML, Hautzinger M, Heilbronner U, Herms S, Hipolito M, Hoffmann P, Holland D, Huckins L, Jamain S, Johnson JS, Juréus A, Kandaswamy R, Karlsson R, Kennedy JL, Kittel-Schneider S, Knowles JA, Kogevinas M, Koller AC, Kupka R, Lavebratt C, Lawrence J, Lawson WB, Leber M, Lee PH, Levy SE, Li JZ, Liu C, Lucae S, Maaser A, MacIntyre DJ, Mahon PB, Maier W, Martinsson L, McCarroll S, McGuffin P, McInnis MG, McKay JD, Medeiros H, Medland SE, Meng F, Milani L, Montgomery GW, Morris DW, Mühleisen TW, Mullins N, Nguyen H, Nievergelt CM, Nordin Adolfsson A, Nwulia EA, O’Donovan C, Olde Loohuis LM, Ori APS, Oruc L, Ösby U, Perlis RH, Perry A, Pfennig A, Potash JB, Purcell SM, Regeer EJ, Reif A, Reinbold CS, Rice JP, Rivas F, Rivera M, Roussos P, Ruderfer DM, Ryu E, Sánchez-Mora C, Schatzberg AF, Scheftner WA, Schork NJ, Shannon Weickert C, Shehktman T, Shilling PD, Sigurdsson E, Slaney C, Smeland OB, Sobell JL, Søholm Hansen C, Spijker AT, St Clair D, Steffens M, Strauss JS, Streit F, Strohmaier J, Szelinger S, Thompson RC, Thorgeirsson TE, Treutlein J, Vedder H, Wang W, Watson SJ, Weickert TW, Witt SH, Xi S, Xu W, Young AH, Zandi P, Zhang P, Zöllner S, eQTLGen Consortium, BIOS Consortium, Adolfsson R, Agartz I, Alda M, Backlund L, Baune BT, Bellivier F, Berrettini WH, Biernacka JM, Blackwood DHR, Boehnke M, Børglum AD, Corvin A, Craddock N, Daly MJ, Dannlowski U, Esko T, Etain B, Frye M, Fullerton JM, Gershon ES, Gill M, Goes F, Grigoroiu-Serbanescu M, Hauser J, Hougaard DM, Hultman CM, Jones I, Jones LA, Kahn RS, Kirov G, Landén M, Leboyer M, Lewis CM, Li QS, Lissowska J, Martin NG, Mayoral F, McElroy SL, McIntosh AM, McMahon FJ, Melle I, Metspalu A, Mitchell PB, Morken G, Mors O, Mortensen PB, Müller-Myhsok B, Myers RM, Neale BM, Nimgaonkar V, Nordentoft M, Nöthen MM, O’Donovan MC, Oedegaard KJ, Owen MJ, Paciga SA, Pato C, Pato MT, Posthuma D, Ramos-Quiroga JA, Ribasés M, Rietschel M, Rouleau GA, Schalling M, Schofield PR, Schulze TG, Serretti A, Smoller JW, Stefansson H, Stefansson K, Stordal E, Sullivan PF, Turecki G, Vaaler AE, Vieta E, Vincent JB, Werge T, Nurnberger JI, Wray NR, Di Florio A, Edenberg HJ, Cichon S, Ophoff RA, Scott LJ, Andreassen OA, Kelsoe J, Sklar P, Bipolar Disorder Working Group of the Psychiatric Genomics Consortium. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 2019;51(5):793-803. https://doi.org/10.1038/s41588-019-0397-8

Rolstad S, Pålsson E, Ekman CJ, Eriksson E, Sellgren C, Landén M. Polymorphisms of dopamine pathway genes NRG1 and LMX1A are associated with cognitive performance in bipolar disorder. Bipolar Disord. 2015;17(8):859–68. https://doi.org/10.1111/bdi.12347

de Bartolomeis A, Buonaguro EF, Iasevoli F, Tomasetti C. The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment. J Psychopharmacol. 2014;28(6):505–26. https://doi.org/10.1177/0269881114523864

Rowland TA, Marwaha S. Epidemiology and risk factors for bipolar disorder. Therapeutic Advances in Psychopharmacology. 2018;8(9):251–69. https://doi.org/10.1177/ 2045125318769235

Tan J, Lin Y, Su L, Yan Y, Chen Q, Jiang H, Wei Q, Gu L. Association between DAOA gene polymorphisms and the risk of schizophrenia, bipolar disorder and depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2014;51:89–98. https://doi.org/10.1016/j.pnpbp.2014.01.007

Zebarjad F, Saadat M. Association between 15 Insertion/Deletion Polymorphisms and the Risk of Type 1 Bipolar Disorder. Gene Expression. 2025;24(2):95-101. https://doi.org/10.14218/GE.2023.00159

Oliva V, Fico G, Prisco MD, Gonda X, Rosa AR, Vieta E. Bipolar disorders: an update on critical aspects. Lancet Reg Health Eur. 2025;48. https://doi.org/10.1016/j.lanepe.2024.101135

Scaini G, Valvassori SS, Diaz AP, Lima CN, Benevenuto D, Fries GR, Quevedo J. Neurobiology of bipolar disorders: a review of genetic components, signaling pathways, biochemical changes, and neuroimaging findings. Braz J Psychiatry. 2020;42(5):536–51. https://doi.org/10.1590/1516-4446-2019-0732

Kalcev G, Preti A, Scano A, Orrù G, Carta MG. Insight into susceptibility genes associated with bipolar disorder: a systematic review. Eur Rev Med Pharmacol Sci. 2021;25(18):5701–24. https://doi.org/10.26355/eurrev_202109_26789

Maletic V, Raison C. Integrated neurobiology of bipolar disorder. Front Psychiatry. 2014;5:98. https://doi.org/10.3389/fpsyt.2014.00098

Grunze H. Chapter 40 - Bipolar Disorder. In: Zigmond MJ, Rowland LP, Coyle JT, editors. Neurobiology of Brain Disorders. San Diego: Academic Press; 2015. p. 655–73. https://doi.org/10.1016/B978-0-12-398270-4.00040-9

Newberg AR, Catapano LA, Zarate CA, Manji HK. Neurobiology of bipolar disorder. Expert Rev Neurother. 2008;8(1):93–110. https://doi.org/10.1586/14737175.8.1.93

Andreazza AC, Young LT. The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment. Int J Neuropsychopharmacol. 2014;17(7):1039–52. https://doi.org/10.1017/S1461145713000096

Sun Z, Ma Y, Li W, He J, Li J, Yang X, Mao P, Cubells JF, Tang YL. Associations between the DBH gene, plasma dopamine β-hydroxylase activity and cognitive measures in Han Chinese patients with schizophrenia. Schizophr Res. 2018;193:58–63. https://doi.org/10.1016/j.schres.2017.06.028

Gonzalez-Lopez E, Vrana KE. Dopamine beta-hydroxylase and its genetic variants in human health and disease. J Neurochem. 2020;152(2):157–81. https://doi.org/10.1111/jnc.14893

Sun Z, Bo Q, Mao Z, Li F, He F, Pao C, Li W, He Y, Ma X, Wang C. Reduced Plasma Dopamine-β-Hydroxylase Activity Is Associated With the Severity of Bipolar Disorder: A Pilot Study. Front Psychiatry. 2021;12:566091. https://doi.org/10.3389/fpsyt.2021.566091

Perry SE, Summar ML, Phillips JA, Robertson D. Linkage analysis of the human dopamine beta-hydroxylase gene. Genomics. 1991;10(2):493–5. https://doi.org/10.1016/0888-7543(91)90339-g

Shakiba M, Hashemi M, Shahrabadi S, Rezaei M, Taheri M. Lack of Association Between Dopamine Beta-Hydroxylase (DBH) 19-bp Insertion/Deletion Polymorphism and Risk of Schizophrenia. Iran J Psychiatry. 2016;11(4):239–43. https://doi.org/10.1159/000495238

Hui L, Zhang X, Huang XF, Han M, Fernandez F, Yu Y, Sun S, Li W, Chen DC, Xiu MH, Kosten TR, Zhang XY. The dopamine b-hydroxylase 19 bp insertion/deletion polymorphism was associated with first-episode but not medicated chronic schizophrenia. J Psychiatr Res. 2012;46(6):733‑7. https://doi.org/10.1016/j.jpsychires.2012.02.016

Mustapic M, Maihofer AX, Mahata M, Chen Y, Baker DG, O’Connor DT, Nievergelt CM. The catecholamine biosynthetic enzyme dopamine β-hydroxylase (DBH): first genome-wide search positions trait-determining variants acting additively in the proximal promoter. Hum Mol Genet. 2014;23(23):6375–84. https://doi.org/10.1093/hmg/ddu332

Andreou D, Saetre P, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG. D-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians. Eur Arch Psychiatry Clin Neurosci. 2012;262(7):549–56. https://doi.org/10.1007/s00406-012-0313-z

Ahmadi L, Kazemi Nezhad SR, Behbahani P, Khajeddin N, Pourmehdi-Boroujeni M. Genetic Variations of DAOA (rs947267 and rs3918342) and COMT Genes (rs165599 and rs4680) in Schizophrenia and Bipolar I Disorder. Basic Clin Neurosci. 2018;9(6):429–38. https://doi.org/10.32598/bcn.9.6.429

Young AH, Juruena MF. The Neurobiology of Bipolar Disorder. In: Young AH, Juruena MF, editors. Bipolar Disorder: From Neuroscience to Treatment. Cham: SpringerM 2020. p. 179. (Current Topics in Behavioral Neurosciences; Vol 48). https://doi.org/10.1007/7854_2020_179

Serretti A, Mandelli L. The genetics of bipolar disorder: genome “hot regions,” genes, new potential candidates and future directions. Mol Psychiatry. 2008;13(8):742–71. https://doi.org/10.1038/mp.2008.29

Gatt JM, Burton KLO, Williams LM, Schofield PR. Specific and common genes implicated across major mental disorders: a review of meta-analysis studies. J Psychiatr Res. 2015;60:1–13. https://doi.org/10.1016/j.jpsychires.2014.09.014

Ates O, Celikel FC, Taycan SE, Sezer S, Karakus N. Association between 1603C>T polymorphism of DBH gene and bipolar disorder in a Turkish population. Gene. 2013;519(2):356–9. https://doi.org/10.1016/j.gene.2013.01.031

Boukhenaf Y, Ayachi OS, Achou R, Bernou AI, Madoui FZ, Sifi K, Rezgoun ML. Association of dopamine receptor D2 -141C insertion/deletion and dopamine beta-hydroxylase 19 bp insertion/deletion polymorphisms with schizophrenia: A case-control study in the eastern Algerian population. Arch Biol Sci. 2024;76(3):313-24. https://doi.org/10.2298/ABS240526023B

Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, Berrettini W, Byerley W, Coryell W, Craig D, Edenberg HJ, Eskin E, Foroud T, Gershon E, Greenwood TA, Hipolito M, Koller DL, Lawson WB, Liu C, Lohoff F, McInnis MG, McMahon FJ, Mirel DB, Murray SS, Nievergelt C, Nurnberger J, Nwulia EA, Paschall J, Potash JB, Rice J, Schulze TG, Scheftner W, Panganiban C, Zaitlen N, Zandi PP, Zöllner S, Schork NJ, Kelsoe JR. Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry. 2009;14(8):755–63. https://doi.org/10.1038/mp.2009.43

Bass NJ, Datta SR, McQuillin A, Puri V, Choudhury K, Thirumalai S, , Lawrence J, Quested D, Pimm J, Curtis D, Gurling HMD. Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia. Behav Brain Funct. 2009;5(1):28. https://doi.org/10.1186/1744-9081-5-28

Müller DJ, Zai CC, Shinkai T, Strauss J, Kennedy JL. Association between the DAOA/G72 gene and bipolar disorder and meta-analyses in bipolar disorder and schizophrenia. Bipolar Disorders. 2011;13(2):198–207. https://doi.org/10.1111/j.1399-5618.2011.00905.x

Gaysina D, Cohen-Woods S, Chow PC, Martucci L, Schosser A, Ball HA, Tozzi F, Perry J, Muglia P, Kennedy JL, King N, Vincent JB, Parikh SV, Strauss J, Craig IW, McGuffin P, Farmer A. Association analysis of DAOA and DAO in bipolar disorder: results from two independent case-control studies. Bipolar Disorders. 2010;12(5):579–81. https://doi.org/10.1111/j.1399-5618.2010.00837.x

Schumacher J, Jamra RA, Freudenberg J, Becker T, Ohlraun S, Otte ACJ, Tullius M, Kovalenko S, Van Den Bogaert A, Maier W, Rietschel M, Propping P, Nöthen MM, Cichon S. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry. 2004;9(2):203–7. https://doi.org/10.1038/sj.mp.4001421

American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5TM. 5th ed. Arlington, VA, US: American Psychiatric Publishing, Inc.; 2013. xliv, 947 p. (Diagnostic and statistical manual of mental disorders: DSM-5TM).

Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res. 1988;16(3):1215. https://doi.org/10.1093/nar/16.3.1215

Kirov G, Jones I, McCandless F, Craddock N, Owen MJ. Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5. Mol Psychiatry. 1999;4(6):558–65. https://doi.org/10.1038/sj.mp.4000565

Hess C, Reif A, Strobel A, Boreatti-Hümmer A, Heine M, Lesch KP, Jacob CP. A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. J Neural Transm. 2009;116(2):121–30. https://doi.org/10.1007/s00702-008-0138-0

Togsverd M, Werge TM, Tankó LB, Bagger YZ, Hansen T, Qin G, Christiansen C, Rasmussen HB. Association of a dopamine beta-hydroxylase gene variant with depression in elderly women possibly reflecting noradrenergic dysfunction. J Affect Disord. 2008;106(1–2):169–72. https://doi.org/10.1016/j.jad.2007.06.010

Zhou Y, Wang J, He Y, Zhou J, Xi Q, Song X, Ye Y, Ying B. Association between dopamine beta-hydroxylase 19-bp insertion/deletion polymorphism and major depressive disorder. J Mol Neurosci. 2015;55(2):367–71. https://doi.org/10.1007/s12031-014-0339-y

Zhang XY, Chen DC, Xiu MH, Hui L, Liu H, Luo X, Zuo L, Zhang H, Kosten TA, Kosten TR. Association of functional dopamine-beta-hydroxylase (DBH) 19 bp insertion/deletion polymorphism with smoking severity in male schizophrenic smokers. Schizophrenia Research. 2012;141(1):48–53. https://doi.org/10.1016/j.schres.2012.07.011

Yamamoto K, Cubells JF, Gelernter J, Benkelfat C, Lalonde P, Bloom D, Lal S, Labelle A, Turecki G, Rouleau GA, Joober R. Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association study. Am J Med Genet B Neuropsychiatr Genet. 2003;117B(1):33–8. https://doi.org/10.1002/ajmg.b.10011

Tang Y lang, Epstein MP, Anderson GM, Zabetian CP, Cubells JF. Genotypic and haplotypic associations of the DBH gene with plasma dopamine β-hydroxylase activity in African Americans. Eur J Hum Genet. 2007;15(8):878–83. https://doi.org/10.1038/sj.ejhg.5201838

Howe AS, Leung T, Bani-Fatemi A, Souza R, Tampakeras M, Zai C, Kennedy JL, Strauss J, De Luca V. Lack of association between dopamine-β hydroxylase gene and a history of suicide attempt in schizophrenia: comparison of molecular and statistical haplotype analyses. Psychiatric Genetics. 2014;24(3):110. https://doi.org/10.1097/YPG.0000000000000031

Cubells JF, Sun X, Li W, Bonsall RW, McGrath JA, Avramopoulos D, Lasseter VK, Wolyniec PS, Tang YL, Mercer K, Pulver AE, Elston RC. Linkage analysis of plasma dopamine β-hydroxylase activity in families of patients with schizophrenia. Hum Genet. 2011;130(5):635–43. https://doi.org/10.1007/s00439-011-0989-6

Ji N, Shuai L, Chen Y, Liu L, Li H, Li Z, Yang L, Qian Q, Tang YL, Cubells JF, Wang Y. Dopamine β-hydroxylase gene associates with stroop color-word task performance in Han Chinese children with attention deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2011;156B(6):730–6. https://doi.org/10.1002/ajmg.b.31215

Schulze TG, Ohlraun S, Czerski PM, Schumacher J, Kassem L, Deschner M, Gross M, Tullius M, Heidmann V, Kovalenko S, Abou Jamra R, Becker T, Leszczynska-Rodziewicz A, Hauser J, Illig T, Klopp N, Wellek S, Cichon S, Henn FA, McMahon FJ, Maier W, Propping P, Nöthen MM, Rietschel M. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes. Am J Psychiatry. 2005;162(11):2101–8. https://doi.org/10.1176/appi.ajp.162.11.2101

Zhang Z, Li Y, Zhao Q, Huang K, Wang P, Yang P, Li S, Feng G, Lindpaintner K, He L, Shi Y. First evidence of association between G72 and bipolar disorder in the Chinese Han population. Psychiatr Genet. 2009;19(3):151–3. https://doi.org/10.1097/YPG.0b013e32832a50f1

Gomez L, Wigg K, Feng Y, Kiss E, Kapornai K, Tamás Z, Mayer L, Baji I, Daroczi G, Benak I, Kothencne VO, Dombovari E, Kaczvinszk E, Besnyo M, Gadoros J, King N, Szekely J, Kovacs M, Vetro A, Kennedy JL, Barr CL. G72/G30 (DAOA) and juvenile-onset mood disorders. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(7):1007–12. https://doi.org/10.1002/ajmg.b.30904

Gawlik M, Wehner I, Mende M, Jung S, Pfuhlmann B, Knapp M, Stöber G. The DAOA/G30 locus and affective disorders: haplotype based association study in a polydiagnostic approach. BMC Psychiatry. 2010;10:59. https://doi.org/10.1186/1471-244X-10-59

Prata D, Breen GD, Osborne S, Munro J, St Clair DM, Collier D. Association of DAO and G72(DAOA)/G30 genes with bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(6):914–7. https://doi.org/10.1002/ajmg.b.30682

Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, Bougueleret L, Barry C, Tanaka H, La Rosa P, Puech A, Tahri N, Cohen-Akenine A, Delabrosse S, Lissarrague S, Picard FP, Maurice K, Essioux L, Millasseau P, Grel P, Debailleul V, Simon AM, Caterina D, Dufaure I, Malekzadeh K, Belova M, Luan JJ, Bouillot M, Sambucy JL, Primas G, Saumier M, Boubkiri N, Martin-Saumier S, Nasroune M, Peixoto H, Delaye A, Pinchot V, Bastucci M, Guillou S, Chevillon M, Sainz-Fuertes R, Meguenni S, Aurich-Costa J, Cherif D, Gimalac A, Van Duijn C, Gauvreau D, Ouellette G, Fortier I, Raelson J, Sherbatich T, Riazanskaia N, Rogaev E, Raeymaekers P, Aerssens J, Konings F, Luyten W, Macciardi F, Sham PC, Straub RE, Weinberger DR, Cohen N, Cohen D. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A. 2002;99(21):13675–80. https://doi.org/10.1073/pnas.182412499

Grigoroiu-Serbanescu M, Herms S, Diaconu CC, Jamra RA, Meier S, Bleotu C, Neagu AI, Prelipceanu D, Sima D, Gherghel M, Mihailescu R, Rietschel M, Nöthen MM, Cichon S, Mühleisen TW. Possible association of different G72/G30 SNPs with mood episodes and persecutory delusions in bipolar I Romanian patients. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(4):657–63. https://doi.org/10.1016/j.pnpbp.2010.03.008

Alves V de M, Pereira e Silva AC, Neto VL de M, Andrade TG, Nardi AE. Associations between genetic polymorphisms and bipolar disorder. Rev Psiq Clin. 2012;39(1):34–9.

Sigitova E, Fišar Z, Hroudová J, Cikánková T, Raboch J. Biological hypotheses and biomarkers of bipolar disorder. Psychiatry Clin Neurosci. 2017;71(2):77–103. https://doi.org/10.1111/pcn.12476

Gigante AD, Bond DJ, Lafer B, Lam RW, Young LT, Yatham LN. Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord. 2012;14(5):478–87. https://doi.org/10.1111/j.1399-5618.2012.01033.x

Zuliani R, Moorhead TWJ, Job D, McKirdy J, Sussmann JED, Johnstone EC, , Johnstone EC, Lawrie SM, Brambilla P, Hall J, McIntosh AM. Genetic variation in the G72 (DAOA) gene affects temporal lobe and amygdala structure in subjects affected by bipolar disorder. Bipolar Disord. 2009;11(6):621–7. https://doi.org/10.1111/j.1399-5618.2009.00731.x

Pauli A, Prata DP, Mechelli A, Picchioni M, Fu CHY, Chaddock CA, , Kane F, Kalidindi S, McDonald C, Kravariti E, Toulopoulou T, Bramon E, Walshe M, Ehlert N, Georgiades A, Murray R, Collier DA, McGuire P. Interaction between effects of genes coding for dopamine and glutamate transmission on striatal and parahippocampal function. Hum Brain Mapp. 2013;34(9):2244–58. https://doi.org/10.1002/hbm.22061